These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19243481)

  • 1. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany.
    Augustin M; Radtke M; van Engen A; Ruedig C; Lapp C; Moehling U
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):329-38. PubMed ID: 19243481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
    Augustin M; Peeters P; Radtke M; Moehling U; Lapp C
    Dermatology; 2007; 215(3):219-28. PubMed ID: 17823519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
    Peeters P; Ortonne JP; Sitbon R; Guignard E
    Dermatology; 2005; 211(2):139-45. PubMed ID: 16088161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.
    Sawyer L; Samarasekera EJ; Wonderling D; Smith CH
    Br J Dermatol; 2013 May; 168(5):1095-105. PubMed ID: 23374249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
    Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
    Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of psoriasis therapy with etanercept in Germany.
    Heinen-Kammerer T; Daniel D; Stratmann L; Rychlik R; Boehncke WH
    J Dtsch Dermatol Ges; 2007 Sep; 5(9):762-8. PubMed ID: 17760896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?
    Balkrishnan R; Bhosle MJ; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2010 May; 21(3):178-84. PubMed ID: 19821787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
    Gorgievska Sukarovska B; Lipozencić J
    Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update of the topical treatment of psoriasis].
    Carrascosa JM; Vanaclocha F; Borrego L; Fernández-López E; Fuertes A; Rodríguez-Fernández-Freire L; Zulaica A; Tuneu A; Caballé G; Colomé E; Bordas X; Hernanz JM; Brufau C; Herrera E
    Actas Dermosifiliogr; 2009 Apr; 100(3):190-200. PubMed ID: 19457304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care.
    Marchetti A; Feldman SR; Kimball AB; Anderson RR; Miller LH; Martin J; An P
    Dermatol Online J; 2005 Mar; 11(1):1. PubMed ID: 15748542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current effective topical therapies in the management of psoriasis.
    Kurian A; Barankin B
    Skin Therapy Lett; 2011 Jan; 16(1):4-7. PubMed ID: 21293834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical steroids versus PUVA therapy in moderate plaque psoriasis: a clinical trial along with cost analysis.
    Amirnia M; Khodaeiani E; Fouladi RF; Hashemi A
    J Dermatolog Treat; 2012 Apr; 23(2):109-11. PubMed ID: 21254854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
    van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol cream: a review of its use in the management of psoriasis.
    Segaert S; Duvold LB
    J Dermatolog Treat; 2006; 17(6):327-37. PubMed ID: 17853305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.